Weidu Biotechnology (Xiamen) Limited Liability Company – Trademark Portfolio

Entity Type: 16

Weidu Biotechnology (Xiamen) Limited Liability Company holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SAEKEKE. The owner is based in Xiamen.

Room 205, No.206 Yuanzhong Road

Xinglin Village, Jimei District

Xiamen 361000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SAEKEKE
SAEKEKE
Registered 2020

Trademark Classifications

Weidu Biotechnology (Xiamen) Limited Liability Company's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Weidu Biotechnology (Xiamen) Limited Liability Company have?

Weidu Biotechnology (Xiamen) Limited Liability Company has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Weidu Biotechnology (Xiamen) Limited Liability Company file in?

Weidu Biotechnology (Xiamen) Limited Liability Company files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Weidu Biotechnology (Xiamen) Limited Liability Company's most well-known trademarks?

Weidu Biotechnology (Xiamen) Limited Liability Company's registered trademark portfolio includes well-known marks such as SAEKEKE. These are among 1 currently registered trademark in the portfolio.

What is Weidu Biotechnology (Xiamen) Limited Liability Company's trademark registration success rate?

Weidu Biotechnology (Xiamen) Limited Liability Company has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.